Position in NMRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,409,185
+$739,193 QoQ
Shares Held
828,933
+141.3% QoQ
Ownership
0.441%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 111 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NMRA Over Time
Shares Held
Position Value (USD)
Derivatives in NMRA
reported options exposure · as of Jun 30, 2026CallValue
$256,020
CallShares
150,600
PutValue
$151,640
PutShares
89,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,839,618 across 436 Biotechnology names. NMRA ranks #214 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in NMRA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,020 | 150,600 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $151,640 | 89,200 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $1,409,185 | 828,933 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $70,005 | 35,900 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $80,730 | 41,400 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $669,992 | 343,586 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,196 | 12,400 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $905,387 | 505,803 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $62,292 | 34,800 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $79,534 | 43,700 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $184,366 | 101,300 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $39,948 | 54,500 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $12,598 | 17,187 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $55,341 | 75,500 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $127,100 | 127,100 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $102,600 | 102,600 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $3,131,240 | 295,400 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $1,327,120 | 125,200 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,534,551 | 144,769 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $924 | 70 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $974,898 | 73,800 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $51,519 | 3,900 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $30,473 | 3,100 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $282,121 | 28,700 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $8,458,154 | 860,443 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $25,079,766 | 1,823,983 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $66,000 | 4,800 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $61,875 | 4,500 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $31,428,111 | 1,843,291 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $92,070 | 5,400 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $11,935 | 700 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $30,597,788 | 2,168,518 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||